12
Views
2
CrossRef citations to date
0
Altmetric
Research

Patent Analysis Anti-infectives: Antituberculosis drugs: Patent analysis 1990–1995

Pages 187-190 | Published online: 29 Feb 2008
 

Abstract

Tuberculosis (TB) is an acute or chronic infection caused by Mycobacterium tuberculosis and is today, the leading cause of death from a single infectious pathogen. Since the outbreak of HIV, the occurrence of tuberculosis has increased dramatically and the World Health Organisation has declared TB a global emergency. This article highlights the patenting trends in this area and comments on compounds which are currently under preclinical evaluation or in Phase I or II clinical trials.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.